Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
US10335388B2 · kind B2 · utility
3Cited by
16References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2016 |
| Grant date | Jul 2, 2019 |
| Priority date | — |
| Expiry date | Apr 14, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods and pharmaceutical compositions for treating proliferative disorders. The method involves step of administering to said subject a HIF-2alpha inhibitor and an immunotherapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.